GENPHARMASEC
Back to Balance Sheet
|
GENPHARMASEC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹9.84 Cr | ₹2.70 Cr | ₹2.06 Cr |
What is the latest Total Current Liabilities ratio of GENPHARMASEC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹9.84 Cr |
| Mar2024 | ₹2.70 Cr |
| Mar2023 | ₹2.06 Cr |
How is Total Current Liabilities of GENPHARMASEC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.84 Cr | 264.03 | |
| Mar2024 | ₹2.70 Cr | 30.91 | |
| Mar2023 | ₹2.06 Cr | - | |
Compare Total Current Liabilities of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹43.2 Cr | -15.2% | -41.4% | -58.4% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹5,874.7 Cr | -1.7% | -16.3% | -22.8% | Stock Analytics | |
| KIRI INDUSTRIES | ₹2,021.6 Cr | -6.1% | -25.8% | -44% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,365.5 Cr | 2.2% | -10.1% | -40.9% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹975.3 Cr | 9.5% | -4.1% | 5.3% | Stock Analytics | |
| BODAL CHEMICALS | ₹645.3 Cr | -10% | 9.1% | -13.1% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -15.2% |
-41.4% |
-58.4% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses